Drug Shortage Report for CESAMET

Last updated on 2018-02-16 History
Report ID 3308
Drug Identification Number 02312263
Brand name CESAMET
Common or Proper name CESAMET
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) NABILONE
Strength(s) 0.25MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 50
ATC code A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2018-02-15
Actual start date
Estimated end date 2018-05-15
Actual end date 2018-02-15
Shortage status Resolved
Updated date 2018-02-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2018-02-16 French Compare
v7 2018-02-16 English Compare
v6 2018-02-16 English Compare
v5 2018-01-23 French Compare
v4 2018-01-23 English Compare
v3 2017-06-16 English Compare
v2 2017-03-17 French Compare
v1 2017-03-17 English Compare

Showing 1 to 8 of 8